Literature DB >> 30289124

Correction: Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists.

Yongkai Cao1,2,3, Ningning Sun2, Jiumei Zhang3, Zhiguo Liu4, Yi-Zhe Tang3, Zhengzhi Wu3, Kyeong-Man Kim2, Seung Hoon Cheon2.   

Abstract

[This corrects the article DOI: 10.1039/C8MD00237A.].

Entities:  

Year:  2018        PMID： 30289124      PMCID： PMC6148686          DOI： 10.1039/c8md90042f

Source DB:  PubMed          Journal:  Medchemcomm        ISSN： 2040-2503            Impact factor:   3.597


The authors regret the following errors in their manuscript: in the Abstract, in the sentence beginning ‘Molecular docking demonstrated…’, ‘Phe7.39’ should be changed to ‘Tyr7.35’. In section ‘2.4 Molecular basis of selectivity over D2R’, in the sentence beginning ‘Notably, the different orientations…’, ‘Phe365/429’ should be changed to ‘Tyr365/429’. In section ‘3. Conclusion’, in the sentence beginning ‘The different orientations…’, ‘Phe7.39’ should be changed to ‘Tyr7.35’. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
  1 in total

1.  Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.

Authors:  Amy E Moritz; R Benjamin Free; Warren S Weiner; Emmanuel O Akano; Disha Gandhi; Ara Abramyan; Thomas M Keck; Marc Ferrer; Xin Hu; Noel Southall; Joseph Steiner; Jeffrey Aubé; Lei Shi; Kevin J Frankowski; David R Sibley
Journal:  J Med Chem       Date:  2020-05-12       Impact factor: 7.446
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.